A recent resurgence of mumps in the US has been linked to a...
- Tracing the story of mumps: a timeline
- Could focusing on the user experience reinvent drug R&D software?
- World Malaria Day 2018: to achieve eradication, malaria transmission must be stopped
- The late-stage type 2 diabetes pipeline is dominated by ‘me-too’ drugs
- New therapy set to dominate the HIV market
Could focusing on the user experience reinvent drug R&D software?
Poorly designed software leads to frustrated scientists and an inefficient R&D process. The Pistoia Alliance is promoting user experience principles to tackle this issue and accelerate life sciences innovation.
World Malaria Day 2018: to achieve eradication, malaria transmission must be stopped
On 25 April, the World Health Organization (WHO) member states celebrate World Malaria Day. This year’s theme, ‘Ready to Beat Malaria’, highlights the collective goal of the global malaria community – a malaria-free world.
The late-stage type 2 diabetes pipeline is dominated by ‘me-too’ drugs
Type 2 diabetes (T2D) is a chronic disease characterised by insulin resistance and pancreatic β-cell failure, with an underlying genetic predisposition that is heavily influenced by diet and lifestyle.
Tweaking diabetes treatments can improve effectiveness
Research carried out by Imperial College London has showed that small alterations to existing diabetes treatments can increase their effectiveness by changing their interactions with cells.
Topas partners with Boehringer for vector-based drugs
German biotechnology company Topas Therapeutics has partnered with Boehringer Ingelheim to focus on antigen-specific tolerance induction to tackle anti-drug antibodies (ADA).
Ketamine may become a key therapy in the treatment of depression
Yale University has found that a single dose of nasal spray ketamine (esketamine) reduces acute symptoms of depression (at 4 and 24 hours) and suicidal thoughts in patients with an imminent suicide risk.
Baccinex Awards Telstar the Design and Construction of Aseptic Filling Process Plant
Baccinex has entrusted Telstar with the design and construction of a cleanroom installation to accommodate an aseptic and lyophilised filling process line, enlarging the existing pharmaceutical plant in the Switzerland region of Jura.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.